Research Output

Filter
Letter
2020

Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients

Coltro, G., Antelo, G., Lasho, T. L., Finke, C. M., Pardanani, A., Gangat, N., Carr, R. M., Binder, M., Mangaonkar, A. A., Ketterling, R., Fernandez-Zapico, M. E., Robertson, K. D., Bosi, A., Vannucchi, A. M., Tefferi, A. & Patnaik, M. M., 2020, (Accepted/In press) In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access

Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Antelo, G., Mangaonkar, A. A., Coltro, G., Buradkar, A., Lasho, T. L., Finke, C., Carr, R., Binder, M., Gangat, N., Al-Kali, A., Elliott, M. A., King, R. L., Howard, M., Melody, M. E., Hogan, W., Litzow, M. R., Tefferi, A., Fernandez-Zapico, M. E., Komrokji, R. & Patnaik, M. M., Jan 1 2020, (Accepted/In press) In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access
2019

Reply to A.S. Garden

Ma, D. J., Price, K. A., Moore, E. J., Patel, S. H., Hinni, M. L., Garcia, J. J., Graner, D. E., Neben-Wittich, M., Garces, Y. I., Chintakuntlawar, A. V., Price, D. L., Van Abel, K. M., Kasperbauer, J. L., Janus, J. R., Waddle, M., Miller, R. C., Shiraishi, S., Mutter, R. W., Corbin, K. S., Park, S. S. & 1 others, Foote, R., Jan 1 2019, In : Journal of Clinical Oncology. 37, 36, p. 3559-3561 3 p.

Research output: Contribution to journalLetter

Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort

Sanhueza, C. T., Huffman, B. M., Jin, Z., Hartgers, M. L., Smyrk, T. C., Westin, G., Mc Williams, R. R., Ma, W. W., Alberts, S. R. & Mahipal, A., Apr 1 2019, In : Pancreas. 48, 4, p. E21-E22

Research output: Contribution to journalLetter

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

Kumar, A. B., Aguilera, J. V., Velazquez, A., Yan, Y., Jakub, J., Brewer, J. D., Hieken, T., Block, M., McWilliams, R., Otley, C., Markovic, S. & Kottschade, L., Jan 1 2019, In : Dermatologic Therapy. e12813.

Research output: Contribution to journalLetter

Two Cases of Krukenberg Tumors from ALK-Rearranged Lung Adenocarcinoma: An Uncommon Site of Metastasis

Ogden, J. J., Xie, H., Marks, R. S. & Leventakos, K., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. e229-e230

Research output: Contribution to journalLetter

2016

Failure to detect DNA-guided genome editing using Natronobacterium gregoryi Argonaute

Lee, S. H., Turchiano, G., Ata, H., Nowsheen, S., Romito, M., Lou, Z., Ryu, S. M., Ekker, S. C., Cathomen, T. & Kim, J. S., Nov 28 2016, In : Nature biotechnology. 35, 1, p. 17-18 2 p.

Research output: Contribution to journalLetter

27 Scopus citations
2015

Toxoplasmosis in patients with hematologic malignancies

Chintakuntlawar, A., Kidd, M., Al-Kali, A., Wilson, W. & Thompson, C. A., Feb 1 2015, In : Leukemia and Lymphoma. 56, 2, p. 536-538 3 p.

Research output: Contribution to journalLetter

6 Scopus citations
2014

Drug-drug interaction between bosutinib and warfarin

Chintakuntlawar, A. V., Finnes, H. D., Tefferi, A. & Pardanani, A., Sep 2014, In : Leukemia and Lymphoma. 55, 9, p. 2213-2214 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
2013

Response to letter by Insall

Seaman, M. N. J., Gautreau, A. & Billadeau, D. D., Nov 1 2013, In : Trends in Cell Biology. 23, 11, p. 520-521 2 p.

Research output: Contribution to journalLetter

2012

Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development

Yee, D., Haddad, T., Albain, K., Barker, A., Benz, C., Boughey, J., Buxton, M., Chien, A. J., DeMichele, A., Dilts, D., Elias, A., Haluska, P., Hogarth, M., Hu, A., Hytlon, N., Kaplan, H. G., Kelloff, G. G., Khan, Q., Lang, J., Leyland-Jones, B. & 18 others, Liu, M., Nanda, R., Northfelt, D., Olopade, O. I., Park, J., Parker, B., Parkinson, D., Pearson-White, S., Perlmutter, J., Pusztai, L., Symmans, F., Rugo, H., Tripathy, D., Wallace, A., Wholley, D., Van't Veer, L., Berry, D. A. & Esserman, L., Dec 20 2012, In : Journal of Clinical Oncology. 30, 36, p. 4584-4586 3 p.

Research output: Contribution to journalLetter

11 Scopus citations

GLI1 modulates EMT in pancreatic cancer - Response

Joost, S., Almada, L. L., Rohnalter, V., Holz, P. S., Fernandez-Barrena, M. G., Fernandez-Zapico, M. E. & Lauth, M., Jul 15 2012, In : Cancer research. 72, 14, p. 3704-3705 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2010

Insulin receptor A and IGF-IR in AML - Response

Wahner Hendrickson, A. E., Haluska, P., Erlichman, C., Gottardis, M., Carboni, J. E., Karp, J. E. & Kaufmann, S. H., Sep 1 2010, In : Cancer research. 70, 17, 1 p.

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2009

Author reply

Bakri, S. J., Reid, J. M., Snyder, M. R., Pulido, J. S. & Singh, R. J., Jan 1 2009, In : Ophthalmology. 116, 1, p. 169-170 2 p.

Research output: Contribution to journalLetter

Interactions between DBC1 and SIRT1 are deregulated in breast cancer cells

Kim, J. E., Lou, Z. & Chen, J., Nov 15 2009, In : Cell Cycle. 8, 22, p. 3784-3785 2 p.

Research output: Contribution to journalLetter

23 Scopus citations
2008

Disorientation: Finding the north

Chintakuntlawar, A., Jan 1 2008, In : Health Affairs. 27, 6, 1 p.

Research output: Contribution to journalLetter

Open Access
2007

Can sorafenib cause hypothyroidism? [3]

Robinson, S. I., Hobday, T. J., Sathananthan, A., Morris, J. C. & McWilliams, R. R., Jun 2007, In : Journal of Chemotherapy. 19, 3, p. 352-353 2 p.

Research output: Contribution to journalLetter

4 Scopus citations

Gemcitabine plus cisplatin in advanced pancreatic cancer [3]

McWilliams, R. R. & Alberts, S. R., Mar 20 2007, In : Journal of Clinical Oncology. 25, 9, 1 p.

Research output: Contribution to journalLetter

2006

Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis [1]

Loegering, D. A., Ruchaud, S., Earnshaw, W. C. & Kaufmann, S. H., Feb 1 2006, In : Cell Death and Differentiation. 13, 2, p. 346-347 2 p.

Research output: Contribution to journalLetter

9 Scopus citations
2005

Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma [4]

McWilliams, R., Highsmith, W. E., Rabe, K. G., De Andrade, M., Tordsen, L. A., Holtegaard, L. M. & Petersen, G. M., Nov 2005, In : Gut. 54, 11, p. 1661-1662 2 p.

Research output: Contribution to journalLetter

41 Scopus citations

The first initiative targeted to increase the training of African-American scientists in pancreatic cancer research: The Mayo Clinic College of Medicine-Oakwood College Alliance

Randriamahefa, A., Fernandez-Zapico, M. E., Mladek, A. C., Evans, L., Melbourne, L., Osborne, S., Cochran, R. L., Knight, M., Beckford, D., Gullo, S., Paul, A., McGee, R. & Urrutia, R., Apr 2005, In : Pancreas. 30, 3, p. 288-291 4 p.

Research output: Contribution to journalLetter

1 Scopus citations
1999

Efficacy of antineoplastons A10 and AS2-1 [1] (multiple letters)

Burzynski, S. R., Buckner, J. C., Reid, J. & Malkin, M., Jan 1 1999, In : Mayo Clinic proceedings. 74, 6, p. 641-642 2 p.

Research output: Contribution to journalLetter

1980

The Clinical Investigator as an Endangered Species

Volpintesta, E. J., Homer, C., Wolski, K. P., Allen, J. C., Kaufmann, S., Cohen, S. R. & Wyngaarden, J. B., Apr 17 1980, In : New England Journal of Medicine. 302, 16, p. 926-928 3 p.

Research output: Contribution to journalLetter

1 Scopus citations